Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Two Concentrations of Nanocrystalline Silver Cream (NPI) Applied Twice Daily in Adults With Mild to Moderate Atopic Dermatitis

NCT00076375 is registered in ClinicalTrials.gov with Nucryst Pharmaceuticals as lead sponsor.

NCT NCT00076375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00076375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Two Concentrations of Nanocrystalline Silver Cream (NPI) Applied Twice Daily in Adults With Mild to Moderate Atopic Dermatitis
Lead sponsor
Nucryst Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2003
Completion date
April 30, 2004
Enrollment
180
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, eczema